Details

The application of genomics technology for analysis of liquid biopsy samples is rapidly growing. In particular, cell-free DNA (cfDNA) is the analyte that has the potential to reveal detailed information on disease progression. 

Tune in to our 3-part video series

  • Multiomic analysis of liquid biopsy samples

                Anna Babayan, Illumina

  • Cell-free DNA Prep with Enrichment library prep kit

                Mariela Cuadras, Illumina

  • Whole exome sequencing of cfDNA in metastatic prostate cancer – customer presentation

                Tina Moser, MedUni Graz

Complete the form to access the video recordings

Your email address is never shared with third parties.

Date & Time
16 Apr 2024
Topic
Cancer research
Watch Now